The triggers cluster into a recognisable set. A long-standing European OEM customer is consolidating production onto US-based platforms and has asked the firm to qualify in the United States to retain the relationship. A first US OEM, US health system, or US federal contracting officer met at IMTS, Hannover Messe USA, MEDICA, RSNA, or RSA has issued an opportunistic RFQ. A second-generation principal who spent three to five years in the United States, often through a US business school, a US engineering rotation, or a US subsidiary leadership role, has returned to the family firm and named the US scale gap as the next decade.
A separate trigger pattern follows US policy shifts. The Inflation Reduction Act and Section 30D battery-localisation rules pulled European OEM consolidation toward US-based plants. The CHIPS and Science Act opened semiconductor and downstream-tooling capex cycles. USMCA rules of origin pulled automotive consolidation into a North American footprint. The Buy American Act, BABA 2021, and the FAR / DFARS clause stack pulled federal procurement into a US-content-first contract. Each shift created a commercial conversation that the German Mittelstand register, calibrated for European procurement, was not prepared for.
A third trigger is private capital. A US private-equity introduction, often through a Frankfurt or Munich family-office advisor, opens a potential US acquisition or US joint-venture path. The firm is suddenly evaluated by US capital partners and US strategic counterparties on US commercial readiness rather than on the home-market track record alone.